CAS NO: | 1005549-94-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Taprenepag isopropyl is a highly selectiveEP2receptoragonist. | ||||||||||||||||
IC50& Target | EP2receptor[1] | ||||||||||||||||
体内研究 (In Vivo) | Taprenepag isopropyl is a highly selective EP2receptor agonist. Intraocular pressure (IOP) in the left, vehicle-dosed eye typically remains within the normal range. In the right (Taprenepag isopropyl-dosed) eye, IOP is reduced in all dose groups. In the high-dose group, IOP is reduced to the extent that it cannot be measured (<4mm hg) on days 22 and 29. there are no clinical signs or changes in body weight observed with any dose of taprenepag isopropyl administration, no ocular findings occur for animals the low-dose group (0.75 mg day)[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 520.60 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C27H28N4O5S | ||||||||||||||||
CAS 号 | 1005549-94-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 200 mg/mL(384.17 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|